e-learning
resources
Copenhagen 2005
Monday 19.09.2005
Pulmonary circulation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical presentation, hemodynamical characteristics and survival of patients with pulmonary arterial hypertension carrying or not a
BMPR2
mutation
B. Sztrymf, A. Yaici, O. Sitbon, G. Simonneau, M. Humbert (Clamart, France)
Source:
Annual Congress 2005 - Pulmonary circulation
Session:
Pulmonary circulation
Session type:
Thematic Poster Session
Number:
2289
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Sztrymf, A. Yaici, O. Sitbon, G. Simonneau, M. Humbert (Clamart, France). Clinical presentation, hemodynamical characteristics and survival of patients with pulmonary arterial hypertension carrying or not a
BMPR2
mutation. Eur Respir J 2005; 26: Suppl. 49, 2289
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
The definition of pulmonary hypertension: history, practical implications and current controversies
Asbestosis
Related content which might interest you:
Clinical characteristics, hemodynamics and survival in idiopathic and familial pulmonary arterial hypertension with germline BMPR2 mutation
Source: Eur Respir J 2007; 30: Suppl. 51, 250s
Year: 2007
Phenotype and outcome of pulmonary arterial hypertension patients carrying a
TBX4
mutation
Source: Eur Respir J, 55 (5) 1902340; 10.1183/13993003.02340-2019
Year: 2020
Absence of influence of gender on clinical phenotypes in BMPR2 mutation carriers with pulmonary arterial hypertension from the French registry
Source: Annual Congress 2010 - Pulmonary hypertension updates
Year: 2010
Pre-implantation genetic diagnosis in pulmonary arterial hypertension due to BMPR2 mutation
Source: Eur Respir J 2012; 39: 1534-1535
Year: 2012
Clinical manifestation of hereditary pulmonary arterial hypertension by a ²second hit² mutation in the genes BMPR2 and EIF2AK4
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016
Pulmonary arterial hypertension preceding idiopathic pulmonary fibrosis in a BMPR2 mutation positive patient
Source: Eur Respir Rev 2014; 23: 147-149
Year: 2014
BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension
Source: Eur Respir J 2016; 48: 1668-1681
Year: 2016
Screening of pulmonary arterial hypertension in BMPR2 mutation carriers
Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension
Year: 2020
Clinical characteristics, haemodynamics, and survival in patients with combined pulmonary fibrosis and emphysema and associated pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary vascular medicine
Year: 2008
Molecular genetics and clinical features of Chinese idiopathic and heritable pulmonary arterial hypertension patients
Source: Eur Respir J 2012; 39: 597-603
Year: 2012
A critical analysis of survival in pulmonary arterial hypertension
Source: Eur Respir Rev 2012 21:218-222
Year: 2012
Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: role of the pre-capillary component
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017
Clinical, functional and hemodynamic response after six months of sildenafil in patients with pulmonary arterial hypertension
Source: Annual Congress 2007 - Pulmonary circulation
Year: 2007
Impact on survival of pulmonary function abnormalities in pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary hypertension
Year: 2009
Survival and prognostic factors in patients with incident systemic sclerosis-associated pulmonary arterial hypertension from the French registry
Source: Annual Congress 2011 - Clinical features of pulmonary hypertension
Year: 2011
BMPR2 mutations and iron metabolism in pulmonary arterial hypertension patients
Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Year: 2021
Impact of the state of endothelium on clinical and functional parameters in COPD patients with arterial hypertension.
Source: International Congress 2017 – Novel mechanisms and treatments for COPD
Year: 2017
Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease
Source: Eur Respir J, 54 (6) 1900585; 10.1183/13993003.00585-2019
Year: 2019
Hemodynamic phenotypes in systemic sclerosis patients screened for pulmonary hypertension – impact of the new PH-definition
Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept